Company Overview
About Morphle Labs
Morphle Labs is a Bengaluru, India and Boston, Massachusetts-based robotic microscopy and digital pathology company — raising $5 million in Series A funding in November 2025 led by Inflexor Ventures — providing histopathology laboratories with AI-powered physical automation platforms that address the speed and throughput bottlenecks in cancer diagnostics workflows. With 80+ patents filed and products deployed in leading US and European laboratories, Morphle's 100-member team has developed two flagship platforms: RoboTome (a robotic microtome system that slices biopsy tissue blocks at 2x the speed of experienced histotechnologists) and MorphoLens (a high-throughput slide scanner that digitizes 100+ histology slides per hour for digital pathology review). Founded to "revolutionize cancer diagnostics with physical AI," Morphle expands manufacturing, regulatory clearances, and global presence with the Series A.
Business Model & Competitive Advantage
Morphle's digital pathology automation addresses the diagnostic throughput bottleneck that threatens cancer care capacity: pathology departments are facing a significant workforce shortage (the US has 20% fewer pathologists than needed, with demand growing as cancer incidence rises and diagnostic complexity increases) while the histopathology workflow — tissue processing, microtome sectioning, slide staining, mounting, and scanning — contains multiple manual steps that create throughput limitations and quality variability. RoboTome's robotic microtome (automating the delicate 4-micron tissue sectioning that requires trained histotechnologists to perform consistently under fatigue) addresses the tissue preparation bottleneck, while MorphoLens's 100+ slides/hour scanning rate (versus 15-20 slides/hour for standard laboratory scanners) digitizes the slide inventory that enables AI-assisted pathology review.
Competitive Landscape 2025–2026
In 2025, Morphle competes in the digital pathology, histopathology automation, and AI diagnostics market with Leica Biosystems (Danaher subsidiary, NASDAQ: DHR, histology automation), Hamamatsu (Japanese slide scanner manufacturer), and Paige AI (AI pathology, $70M raised) for pathology laboratory digital transformation and cancer diagnostics automation platform adoption. Inflexor Ventures' Series A leadership (Indian deep tech and healthcare VC) reflects conviction in Morphle's India-built hardware for global laboratory markets. The 80+ patent portfolio represents significant IP protection for the robotic microtome innovation. The 2025 strategy focuses on FDA 510(k) clearance for US laboratory deployment, growing European laboratory adoption through CE-marked scanner installation, and building the AI pathology analysis layer for automated slide reading alongside the physical automation platforms.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Morphle Labs is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Compare Morphle Labs with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Morphle Labs? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Morphle Labs Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Morphle Labs vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →